Polyvalent Melanoma Vaccine Improves Survival of Patients with Metastatic Melanomaa
- 1 August 1993
- journal article
- clinical trial
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 690 (1) , 120-134
- https://doi.org/10.1111/j.1749-6632.1993.tb44002.x
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Cytotoxic T cell lines recognize autologous and allogeneic melanomas with shared or cross-reactive HLA-ACancer Immunology, Immunotherapy, 1992
- Prolongation of Survival in Metastatic Melanoma After Active Specific Immunotherapy With a New Polyvalent Melanoma VaccineAnnals of Surgery, 1992
- Induction of CD4+ cytotoxic T cells by sensitization with allogeneic melanomas bearing shared or cross-reactive HLA-ACellular Immunology, 1992
- Modulation of Histamine Type II Receptors on CD8+ T Cells by lnterleukin-2 and CimetidineInternational Archives of Allergy and Immunology, 1992
- A Gene Encoding an Antigen Recognized by Cytolytic T Lymphocytes on a Human MelanomaScience, 1991
- Active specific immunotherapy with vaccinia colon oncolysate enhances the immunomodulatory and antitumor effects of interleukin-2 and interferon α in a murine hepatic metastasis modelCancer Immunology, Immunotherapy, 1990
- Use of Tumor-Infiltrating Lymphocytes and Interleukin-2 in the Immunotherapy of Patients with Metastatic MelanomaNew England Journal of Medicine, 1988
- Immunogenicity of a polyvalent melanoma antigen vaccine in humansCancer, 1988
- BCG lmmunotherapy of Malignant MelanomaAnnals of Surgery, 1974
- Surgical Resection and Adjunctive lmmunotherapy for Selected Patients with Multiple Pulmonary MetastasesAnnals of Surgery, 1973